Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-013069
Filing Date
2024-04-03
Accepted
2024-04-03 20:05:00
Documents
1
Period of Report
2024-03-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1512
  Complete submission text file 0001493152-24-013069.txt   3029
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address
Marshall Richard Peter (Reporting) CIK: 0002016188 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38519 | Film No.: 24821122